EndoVE endosCopic Treatment for Oesophageal and gastric canceR(VECTOR)

• Research type

  Research Study

• Full title

  EndoVE endosCopic Treatment for Oesophageal and gastric canceR (VECTOR)

• IRAS ID

  271623

• Contact name

  Simon Parsons

• Contact email

  simon.parsons@nuh.nhs.uk

• Sponsor organisation

  Mirai Medical Limited

• Clinicaltrials.gov Identifier

  NCT04649372

• Clinicaltrials.gov Identifier

  Mirai QMS Reference, CIP-20-001

• Duration of Study in the UK

  1 years, 1 months, 28 days

• Research summary

  This project aims to establish the safety and efficacy of treating patients with inoperable oesophageal cancer or gastric cancer using an endoscopic electroporation system (EndoVE) to facilitate direct chemotherapy tumour absorption.

• REC name

  North of Scotland Research Ethics Committee 1

• REC reference

  20/NS/0123

• Date of REC Opinion

  16 Nov 2020

• REC opinion

  Further Information Favourable Opinion